Small molecule · Inhibitor of histone deacetylase (HDAC) · developed by Secura
Panobinostat is a histone deacetylase (HDAC) inhibitor that blocks HDAC enzymatic activity at nanomolar concentrations, leading to histone hyperacetylation, chromatin relaxation, cell cycle arrest and apoptosis in transformed cells. It is studied in myelofibrosis, polycythemia vera, graft versus host disease, acute myeloid leukemia and thalassemia.
Summary written with AI from the sources listed at the end of this page.
From the indications section of the FDA label (version of Jul 27, 2021). Read the full label for the exact wording, limitations and safety information.
Acute Myeloid LeukemiaGraft Versus Host DiseasePolycythemia VeraPrimary MyelofibrosisThalassemia
Updated Oct 25, 2026.